Cerebral artery selective inhibition of protein kinase C-mediated contraction by HNS-32, a novel azulene-1-carboxamidine derivative

Citation
K. Noguchi et al., Cerebral artery selective inhibition of protein kinase C-mediated contraction by HNS-32, a novel azulene-1-carboxamidine derivative, RES COM M P, 107(1-2), 2000, pp. 45-54
Citations number
17
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
ISSN journal
10780297 → ACNP
Volume
107
Issue
1-2
Year of publication
2000
Pages
45 - 54
Database
ISI
SICI code
1078-0297(2000)107:1-2<45:CASIOP>2.0.ZU;2-F
Abstract
The vasorelaxant actions of a novel azulene-1-carboxamidine derivative, HNS -32, were investigated on the tension development evoked by phorbol 12, 13 dibutyrate (PDBu) in cerebral and femoral arteries isolated from the dogs. In basilar artery, HNS-32 inhibited almost completely PDBu-induced contract ion in a concentration-dependent manner with potency about 10 times stronge r than that of fasudil, a protein kinase inhibitor. In contrast, in femoral artery, HNS-32 failed to suppress the tension development in response to P DBu whereas fasudil inhibited it with a similar potency as in basilar arter y. These findings indicate that HNS-32 selectively suppresses cerebral arte ry contraction mediated via an activation of protein kinase C.